Contact us via email or phone to learn more about our Rejenevie™ treatments. We’ll step you through the entire process.

The ideal patient candidate would be over 55 years of age, in good health, and have no prior history of blood-borne tumor.

You’ll visit one of our U.S.-based cell collection centers where you will receive Neupogen® (filgrastim) over the course of five days. This will require five separate visits to the collection center. On the sixth day, you will return to the center and undergo a process called leukapheresis.  In this four-to six-hour process, all of the stem cells that have been mobilized into your blood are collected into a blood bag.  After quality testing and freezing of the cells, we transport the cells to storage in our state-of-the-art biorepository until you’re ready for treatment.

When you’re ready for your immune restoration therapy, we’ll schedule your treatment at our clinic in Freeport, Bahamas. The Okyanos Center for Regenerative Medicine is a global leader in delivering advanced stem cell therapies, with world-class physicians and the highest level of patient care.

You should arrive in the Bahamas the day prior to treatment.  You will be greeted at the airport by our concierge service and taken to one of our affiliated hotels.  On the day of treatment, you’ll arrive at the clinic about two hours prior to infusion time.

On the day of treatment, you’ll meet the staff, and have your vital signs taken. When your cells are ready for infusion, they will be delivered via IV, a process that will take only one hour.  Following treatment, you will remain under observation for 30 minutes. If you are feeling well, you can be discharged and sent home the same day.

Potential side effects that we’ve observed occur during the mobilization and collection phase, mainly due to the drug that is provided. These potential side effects include flu-like symptoms and bone pain.

With any experimental treatment, there are potential risks that could occur, however, to date we have not observed any serious adverse events with any of our patients.

You will be tested at one month, three, six, nine, and 12 months.

After treatment, you will undergo periodic blood testing using a kit we’ve developed with one of the world’s leading diagnostic companies.  The kit specifically tests for natural killer cell, B-cell, and T-cell function. This gives us a gauge of overall immune competence.  The kit also tests for certain ratios of immune cells, giving us a further measure of immune function. Finally, safety testing is built into our kit through the use of a blood smear that is analyzed by a clinical pathologist to ensure that there is no evidence of disease.

We will send you a 36-question survey that assesses quality of life measures at three, six, and 12 months. We then analyze your answers for a general idea of your overall health status and any general pain or other issues you might be experiencing.

For a patient who undergoes a successful stem cell mobilization procedure, enough cells are collected to perform at least ten immune restoration treatments at Okyanos.

As with any experimental treatment, results are variable. Because our approach is relatively new, the expected duration of immune restoration is unknown.

Donors for Rejenevie™ immune restoration are completely anonymous to us. They are recruited by the cell collection centers.  The donors are contacted by the collection center where they are evaluated by the center’s doctors and deemed healthy enough to receive the drug. The ideal donor candidate is 18 to 29 years of age, is within a select BMI range, has healthy lifestyle habits including five days a week of moderate to light exercise, good eating and sleep habits.  They should also be a nonsmoker.  We exclude any young donor who has a prior history of cancer or is positive for HIV or hepatitis B or C.

Yes. They are compensated for providing their cells.  For safety and due to potential health concerns with multiple donations, we do not recommend a donor being mobilized more than once.